Pay Now or Pay More

By |2021-06-13T15:49:56+02:00August 1st, 2020|

Pay Now or Pay More Abstract: There is no way to tell exactly what the economic damage from the COVID-19 impact will be, but initial estimates predict most major economies will lose at least 2.4 percent of their GDP over 2020 as a whole (OECD 2020). To put this number in perspective, global [...]

Interdependent Factors of Demand-Side Rationale for Chemical, Biological, Radiological, and Nuclear Medical Countermeasures

By |2021-06-13T15:49:36+02:00November 18th, 2019|

Interdependent Factors of Demand-Side Rationale for Chemical, Biological, Radiological, and Nuclear Medical Countermeasures Abstract: The deliberate use of chemical, biological, radiological, and nuclear (CBRN) materials in war or terrorist attacks is perceived as a great threat globally. In the event of a release of CBRN agents, protection by means of medical countermeasures (MedCMs) [...]

Strengthening the Cost Effectiveness of Medical Countermeasure Development Against Rare Biological Threats: The Ebola Outbreak

By |2023-04-11T15:13:14+02:00October 31st, 2017|

Strengthening the Cost Effectiveness of Medical Countermeasure Development Against Rare Biological Threats: The Ebola Outbreak Abstract: Some chemical, biological, radiological, andnuclear agents, whether naturally, accidentally, or intentionally released, can be very damaging and pose a high risk to national security, owing to their potential for economic and social disruption. Efficacious pharmaceutical research and [...]

When Investment for Medical Countermeasures against Rare, but Dangerous Agents Becomes Cost Effective – The Ebola Case

By |2021-06-13T16:01:31+02:00April 1st, 2016|

When Investment for Medical Countermeasures against Rare, but Dangerous Agents Becomes Cost Effective – The Ebola Case Cost Research Article: Economics surrounding the Ebola Outbreak (short version) Introduction: There are countless chemical, biological, radiological, and nuclear (CBRN) agents that are proficient enough to harm individuals. Examples include viruses (e.g. influenza) and bacteria which [...]

When Investment for Medical Countermeasures against Rare, but Dangerous Agents Becomes Cost Effective – The Ebola Case

By |2021-06-13T16:02:08+02:00January 1st, 2015|

When Investment for Medical Countermeasures against Rare, but Dangerous Agents Becomes Cost Effective – The Ebola Case Cost Research Article: Economics surrounding the Ebola Outbreak (short version) Introduction: There are countless chemical, biological, and radiological (CBR) agents that are proficient enough to harm individuals. Examples include viruses (eg influenza) and bacteria which are [...]

Medical Countermeasures: Challenging the Status Quo

By |2021-06-13T16:03:27+02:00January 14th, 2014|

Medical Countermeasures: Challenging the Status Quo Policy Status Article: CBRN Medical Countermeasures Introduction: The medical countermeasures (MCMs) chapter of the CBRNe World Directory 2013 included a focus on the history of MCMs, required market characteristics to stimulate its availability, and various positions of international institutions and public figureheads concerning the need for relevant [...]

Doctor and the Medics: Mark Johnson on the International Availability of Medical Countermeasures (MCM)

By |2021-06-13T16:04:31+02:00January 14th, 2013|

Doctor and the Medics: Mark Johnson on the International Availability of Medical Countermeasures (MCM) Mark Johnson on the international availability of medical countermeasures (MCM). Introduction: Ratification of the 1925 Geneva Protocol, which prohibits the use of chemical and biological weapons, symbolised a broad determination not to engage in offensive war strategies that deploy weapons [...]

Europe Lacks Medical Countermeasures for Responding to a CBR Terrorist Attack

By |2021-06-13T16:05:02+02:00October 1st, 2012|

Europe Lacks Medical Countermeasures for Responding to a CBR Terrorist Attack Mark Lawrence Johnson creates awareness concering lack of CBRN Medical Countermeasure preparedness. Introduction: Over the last years, the threat that terrorists could resort to using weapons of mass destruction (WMD) such as chemical, biological, and radiological (CBR) agents in Europe has been credibly [...]

Statement of MJ Lawrence Consulting: Seventh Review Conference of the States Parties to the Biological Weapons Convention 2011

By |2021-05-03T20:08:14+02:00December 6th, 2011|

Statement of MJ Lawrence Consulting: Seventh Review Conference of the States Parties to the Biological Weapons Convention 2011 Statement of MJ Lawrence Consulting to the SEVENTH REVIEW CONFERENCE OF THE STATES PARTIES TO THE BIOLOGICAL WEAPONS CONVENTION Introduction: Mr. President, Mr. Secretary-General, and distinguished delegates. Thank you for this opportunity to make a [...]

Euro-View: Mark Johnson on CBR Medical Countermeasures

By |2021-06-13T16:05:33+02:00November 1st, 2011|

Euro-View: Mark Johnson on CBR Medical Countermeasures Mark Lawrence Johnson creates awareness concering lack of CBRN Medical Countermeasure preparedness. Introduction: Over the last years, the threat that terrorists could resort to using weapons of mass destruction (WMD) such as chemical, biological, and radiological (CBR) agents in Europe has been credibly asserted by institutions such [...]

Go to Top